Access for All: Write your representative
The Covid-19 pandemic is driving a transition to virtual and remote care as more and more patients connect with their health care teams online. Diabetes technologies such as CGM and Flash GM support this move to virtual and remote care by reducing in-person visits and advancing clinical innovation to improve health care support for vulnerable Canadians.
Virtual care has the potential to save both time and money and is proving effective in helping patients and families with type 1 diabetes better manage the disease. With CGM and Flash GM, members of the health care team can remotely access real-time data as well as 14-day, 30-day, and 90-day trends of the patient’s blood glucose data. In helping to facilitate patient-focused digital health support, these technologies will foster better care and services closer to home.
However, without government support, this remains out of reach for most Canadians.
Send an email now to your provincial or territorial representative explaining how advanced glucose monitoring devices are life-changing for those with type 1 diabetes (T1D) and how they can help reduce out-of-pocket costs for their constituents.